Study objectives: Previous laboratory studies in narcolepsy patients showed altered core body and skin temperatures, which are hypothesised to be related to a disturbed sleep wake regulation. In this ambulatory study we assessed temperature profiles in normal daily life, and whether sleep attacks are heralded by changes in skin temperature. Furthermore, the effects of three months of treatment with sodium oxybate (SXB) were investigated.
IntroductIon
Core body and skin temperature are closely linked to sleep and alertness. [1] [2] [3] In healthy controls, wake is associated with a relatively high core body temperature and a relatively low skin temperature. 4, 5 The opposite pattern, i.e. a decreased core body temperature and an increased skin temperature, is seen during sleep. Transitions from wake to sleep and vice versa are characterised by changes in these temperatures. Sleep onset is preceded by a decline in core body temperature and an increase in skin temperature. The decrease in core body temperature is mediated through increased skin perfusion, which consequently leads to the increase in skin temperature, facilitating cooling of the body. 5, 6 A relatively high distal skin temperature compared to proximal skin temperature, i.e. a high distal-to-proximal temperature gradient (DPG), was demonstrated to promote sleep onset. 1 When a 'sleepy state of core body and skin temperature' is seen during wake, this is typically associated with lowered vigilance. 7 This may probably be called 'sleep promoting', since it is also seen immediately before sleep onset.
Narcolepsy type 1 (narcolepsy with cataplexy) is a disorder of the regulation of sleep and wakefulness. Besides the pathognomonic symptom cataplexy, narcolepsy patients suffer from excessive daytime sleepiness (EDS), hypnagogic hallucinations, sleep paralysis and disturbed nocturnal sleep. 8, 9 In studies concerning temperature measurements in narcolepsy patients, an altered diurnal temperature profile has been demonstrated in both core body and skin temperature. Narcolepsy patients are reported to have a relatively high daytime distal skin temperature, a lowered proximal skin temperature, and subsequently a higher DPG during daytime. 4, 10, 11 Furthermore, a lower nocturnal distal skin temperature was seen in narcolepsy. 11 Studies regarding core body temperature in narcolepsy were not conclusive. Results vary from an elevated core body temperature to a lowered core body temperature. 4, [12] [13] [14] [15] The hypothesised relationship between an altered temperature pattern and disturbed sleep wake regulation in narcolepsy was supported by temperature manipulation studies. These studies demonstrated that cooling the distal skin resulted in a better ability to maintain wakefulness, and increasing core body temperature improved vigilance during the day. 4 Furthermore, counteracting the altered nocturnal skin temperature pattern by subtle skin temperature manipulations during the night, improved nocturnal sleep. 16 All these previous studies regarding skin temperature and most of the studies concerning core body temperature were performed in a laboratory setting, but whether laboratory findings are representative for actual daily life has not been assessed. The current study was performed to overcome this limitation and to further explore the interaction between temperature regulation and sleep in narcolepsy in normal daily life. We aimed first to assess whether in an ambulatory setting, sleep attacks are heralded by changes in skin temperature. Our second aim was to further explore core body and skin temperature profiles and sleep in narcolepsy type 1 in daily life, before and after stable monotherapy with sodium oxybate (SXB) a widely-used drug to improve nocturnal sleep, cataplexy and EDS in narcolepsy. 17 We expected to confirm the previously found daytime increased distal and lowered proximal skin temperature and consequently an increased DPG. Furthermore, we measured 24h core body temperature patterns during day and night, these patterns have not been studied in detail before.
Patients and controls underwent 24h ambulatory core body and skin temperature measurement together with ambulatory polysomnography. Additionally, the patients who were treated successfully with SXB monotherapy underwent the same measurements after three months stable treatment with SXB. Patients were all naïve to SXB treatment, and were scheduled to start with SXB. The decision for treatment with SXB was part of their therapeutic plan; i.e. no patients were put on SXB treatment for the purpose of participation in this study. 6 patients used narcoleptic medication other than SXB, which was stopped at least 14 days prior to the start of the study.
methods subjects
Fifteen healthy controls (9 male; The Netherlands (N=9); Switzerland (N=6); mean BMI 25.2), free of any neurologic or psychiatric disease were recruited using notices in local newspapers. Controls were matched for age and gender.
Exclusion criteria for both patients and controls were cognitive impairment due to neurological disorders other than sleep-wake disorders, the use of hypnotics or sleep-wake active drugs other than SXB, and age below 18 or above 70 years.
The protocol was approved by the medical ethical committees of both institutions and written informed consent was obtained from all subjects prior to the study.
study design
At baseline, all subjects underwent an ambulatory baseline 24h temperature measurement and polysomnography simultaneously. Following the baseline study, twenty-three patients were treated with SXB by their treating physician. They received the usual therapeutic dose of SXB (4.5-9.0 g/day). Due to side effects and/or environmental factors, seven patients discontinued SXB within three months. Subsequently, after three months stable single-drug treatment a second 24h temperature measurement and polysomnography was performed in sixteen patients. Controls followed the procedure only at baseline.
temperature measurement
The temperature measurement methods have previously been described.11 A wireless monitoring system was used for core body temperature measurement: an ingestible and biocompatible capsule with Vitalsense monitor (Mini Mitter Company Inc., A Respironics, Inc. Company Bend, Oregon, USA). 19 Thermochron iButtons (type DS1921H-F50; Maxim Integrated products, Inc., Sunnyvale, CA, USA) were used for wireless skin temperature measurement. 20 Skin temperature was measured at 7 locations: left infraclavicular area, both hands, abdomen (1 cm above the umbilicus), left midthigh (musculus rectus femoris) and both feet. Distal skin temperature contained the temperatures at medial metatarsal area at the plantar sides of both feet and the thenar area at the palmar side of both hands. 21 Proximal skin temperature was obtained from the infraclavicular, the thigh and abdominal temperature. To calculate the DPG, proximal skin temperature was subtracted from the distal skin temperature.
Both core body temperature and skin temperature were sampled once per minute with a resolution of 0.125°C. 
sleep recording and analysis

sleep
Sleep characteristics are given in Table 5 .1. Due to technical problems, polysomnographic registration failed in one patient, and two controls did not give permission for polysomnographic registration.
During the day, patients were significantly less awake compared to controls (p<0.001).
Subsequently, all sleep stages were more frequently seen during the day in patients compared to controls. Patients were more awake during the night, but spent overall more time asleep during 24 hours. The distribution of sleep stages during the night was similar in patients and controls. In patients, treatment with SXB resulted in an increase of slow Figure 5 .1)
Temperature profiles are shown in Figure 5 .1 and the results of statistical analysis in Furthermore, a significant effect of group by time of day was seen for proximal skin temperature during the day and for both proximal and distal skin temperature during Post-hoc tests indicated a significantly (p<0.05) higher proximal skin temperature in patients between 7:30h and 11:30h, a significantly higher core body temperature in patients between 0:00h and 3:30h, a significantly lower distal skin temperature in patients between 1:00h-4:00h and 5:00h-5:30h, and a significantly higher distal skin temperature in patients between 7:30h-9:30h and 10:30h-11:00h.
A similar analysis was performed anchored to the bedtimes instead of actual clock times. In conclusion, as compared to controls, patients had a higher proximal and distal skin temperature in the morning; and a lower distal skin and a higher core body temperature during the night.
temperature in narcolepsy patients: baseline vs. sXb (table 5.3, Figure 5 .
2)
No significant differences in temperature were seen at baseline compared to during treatment with SXB). Analysis of treatment by time of day revealed a significant effect on proximal skin temperature and nearly on core body temperature (respectively F=2.14, df=7.73, p=0.03; F=1.90, df=6.94, p=0.07). Furthermore, in post-hoc tests core body temperature was lower after SXB treatment from 5:00h to 9:30h. Summarising, treatment with SXB in narcolepsy lowered nocturnal core body temperature to a level seen in controls. Indeed, no significant difference in nocturnal core body temperature was found anymore for patients during treatment with SXB compared to controls (F=0.0, df=1, p=0.94).
the predictive value of temperature changes on the onset of daytime naps (table 5.4, Figure 5 .3)
Since daytime napping was rare in controls, only daytime naps in patients were analysed.
Mixed effects logistic regression analysis in patients at baseline revealed that the probability of sleep onset increased with a higher distal skin temperature (Odds Ratio (OR) and 95%
confidence interval (CI) 1. Core body temperature was excluded from this analysis; due to technical problems, too many core body temperature measurements were missing to perform this analysis reliably.
In patients at baseline 11% of the measurements were missing, during treatment with SXB 3% and in controls 21%.
dIscussIon
We aimed to assess whether in everyday life, sleep attacks are heralded by changes in skin temperature, and to further explore temperature regulation and sleep in narcolepsy type 1.
Interestingly, changes in distal skin temperature and DPG strongly predicted the onset of daytime sleep attacks. Compared to controls, patients had a higher core body temperature during the first part of the night and a different time course of distal skin, proximal skin and core body temperature. Treatment with SXB resulted in normalisation (i.e. lowering) of core body temperature during the night, an increased amount of slow wave sleep during the night and a reduced number of daytime naps.
distal skin temperature and dPG changes are predictive for sleep onset
An exciting finding in the present study is the predictive value of distal skin temperature and DPG in daily life daytime sleep attacks, 30 seconds, 5 minutes, 15 minutes and before sleep onset. In particular, the increase of distal skin temperature and DPG in the five minutes prior to sleep onset are strongly related to the onset of sleep attacks. These findings may be evaluated for possible use as a warning of sleep attack risk in narcolepsy patients. It is tempting to imagine the development of a temperature-driven alarm or even cooling devices, to warn narcolepsy patients or even prevent them from falling asleep when not appropriate. Previous temperature manipulation studies in healthy young and elderly subjects, insomniacs and narcolepsy patients showed that manipulation of skin temperature can influence the ability to maintain wakefulness, daytime vigilance, sleep onset latency and sleep depth. In all subjects, distal skin warming decreased sleep onset latency and enhanced sleep depth. 16, 23, 24 In narcolepsy patients, distal skin cooling increased the ability to maintain wakefulness. 4 In elderly and insomniacs, proximal skin warming markedly slowed the response speed in vigilance tasks. 25 
Altered thermoregulatory profile in narcolepsy
Patients had a higher core body temperature during the first part of the night, which is in line with the only other ambulatory core body temperature study that has been performed in narcolepsy.
14 All other previous studies concerning core body temperature were performed in a laboratory setting, and showed a large variation in methods and results. [11] [12] [13] 15 As high core body temperature is associated with higher vigilance or wakefulness, 4,6 a nightly higher core body temperature might be related to the disturbed nocturnal sleep in narcolepsy.
In previous laboratory studies, 10, 11 daytime proximal skin temperature was repeatedly described to be lower in patients than in controls, a finding that could not be replicated in the current study. Conversely, we even found a higher proximal skin temperature in the morning in patients. However, none of these previous studies included ambulatory patients.
These previous studies were respectively performed when subjects stayed (semi) supine during the measurements, and during a Multiple Sleep Latency Test (MSLT). 10, 11 Since body position directly influences skin and core body temperature, 26 this might be an explanation for the differences between previous findings and ours. As a consequence of the absence of a lowered proximal skin temperature, no higher distal-proximal temperature gradient (DPG) was found in patients. Furthermore, the time course of both distal and proximal skin temperature is similar ( Figure 5 .1), so significant differences in DPG are not expected.
The different time course of distal skin temperature in patients, being higher in the morning and lower during night time, does correspond with the findings in the previous studies. 10, 11 As described in the introduction section, a high distal skin temperature during the day is associated with lowered vigilance and increased sleep propensity, 7 and low distal skin temperature is expected to correspond with an increased maintenance of wakefulness. 4 Subsequently, a lowered nocturnal distal skin temperature might be related to a disturbed nocturnal sleep.
the effects of sXb on temperature profiles in narcolepsy
Patients had an increased nocturnal core body temperature compared to controls prior to treatment, while during treatment with SXB, core body temperature reached levels similar to the levels seen in controls. This normalisation of nocturnal core body temperature might be associated with the known improvement of nocturnal sleep in patients during SXB treatment. 27 However, in our previous study no treatment effects on core body temperature were seen at all. 11 In that study, patients were only treated with SXB for 5 consecutive days, probably a too short period to detect these changes in core body temperature. Furthermore, methodology differed in that patients stayed (semi) supine throughout the whole study. This difference in methodology might as well be an explanation for the absence of an increase,
i.e. normalisation, of daytime proximal skin temperature in patients after treatment with SXB described in our previous study. 11 Nevertheless, based on manipulation studies, 16, 25, 28 an increase of proximal skin temperature lowers vigilance and increases sleep onset. Therefore, this previously found increased daytime proximal skin temperature would be in contradiction with the known effects of SXB, i.e. a reduction of daytime sleep attacks.
limitations
Since previous studies were performed in laboratory settings, the results are not representative for daily life. For this reason, we performed our study ambulatory, which is a benefit in measuring and predicting daytime sleep attacks, however, due to being ambulatory, all circumstances differed between the subjects. Subjects were allowed to follow their usual habits, therefore all bedtimes differed, food and drinks varied as well as their temperatures.
Furthermore, subjects went outside whenever they wanted while the climate differed season by season, and due to technical problems core body temperature measurements were partially incomplete in a few subjects. These differences make the comparison of temperature profiles more difficult, however, we already performed these measurements in a laboratory setting. 29 Moreover, no information about body position, which influences temperature, was available. All these differences probably influenced core body and skin temperatures and its analysis. Moreover, due to several clinical and/or personal reasons, not all included patients started or continued treatment with SXB for a period of at least three months, making the post-treatment group smaller.
conclusions Daytime sleep attacks were preceded by clear changes in skin temperature. An increase in distal skin temperature and DPG during the fifteen minutes, 30 seconds, and even more during the five minutes prior to daytime sleep onset, was highly significantly associated with the occurrence of sleep attacks. It is intriguing to speculate whether these findings in the future might possibly lead to methods to warn narcolepsy patients or prevent falling asleep when not appropriate.
In an ambulatory setting, core body temperature was higher and distal skin temperature lower during the night in narcolepsy patients compared to controls. These changes might be associated with the known disturbed nocturnal sleep in narcolepsy. Furthermore, the previously described higher daytime distal skin temperature was also seen in the present Results of mixed effects logistic regression analysis for patients during treatment with SXB (nights were excluded), indicating effects of temperature fluctuations as regressor for fluctuations in sleep attack probability. Analysis was performed for proximal skin temperature, distal skin temperature or distalproximal temperature gradient (DPG) at the moments: difference between the temperature during the 30-seconds epoch prior to sleep onset and 15 minutes prior to sleep onset, difference between the temperature during the 30-seconds epoch prior to sleep onset and 5 minutes prior to sleep onset, the absolute temperature during the 30-seconds epoch prior to sleep onset. * p<0.05; ** p<0.01.
supplementary Figure s5 .1 mean ± sem temperature profiles of patients vs. controls. Temperature curves anchored on bedtimes instead of real clock times. (A) distal skin temperature in patients (red) and controls (green) at baseline, (B) proximal skin temperature in patients and controls at baseline, (C) distal-proximal temperature gradient (DPG) in patients and controls at baseline (D) core body temperature in narcolepsy patients and controls at baseline. The grey area indicates the period during which the temperature significantly differed according the post-hoc tests (* p<0.05).
suPPlementAry FIGures supplementary Figure s5 .2 mean ± sem temperature profiles of patients at baseline and during sXb administration. Temperature curves anchored on bedtimes instead of real clock times. (A) distal skin temperature in patients at baseline (red) and during SXB administration (blue), (B) proximal skin temperature in patients at baseline and during SXB administration, (C) distal-proximal temperature gradient (DPG) in patients at baseline and during SXB administration, (D) core body temperature in narcolepsy patients at baseline and during SXB administration. The grey area indicates the period during which the temperature significantly differed according the post-hoc tests (* p<0.05).
